Viridian Capital Advisors

Cannabis Defaults Are Piling Up: 3 Companies Just Missed Payments—Who's At Risk Next?

Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study

Cannabis Stocks Plunged After Florida Legalization Failed: Rational Reaction Or Market Overreach?

Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study

Cannabis Stocks Plunged After Florida Legalization Failed: Rational Reaction Or Market Overreach?

Cannabis Debt Looms For These Weed Giants: Here's How Some Tackled Their Financial Challenges

Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025

Cannabis Debt Looms For These Weed Giants: Here's How Some Tackled Their Financial Challenges

|

Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025

|

Why Cannabis Investors Should Make This Bold Move Before Florida's Vote: What To Buy And Sell Now

|

EXCLUSIVE: Tracking Every Cannabis Deal Is 'A Lot Of Fun,' Says Financial Expert Behind Essential Investor Tool

|

Viridian Capital Advisors Recent News

EXCLUSIVE: Cannabis Rescheduling Is Not Cure-All For Industry Problems: Experts Explain How Tax Tactics Could Hurt Marijuana Businesses In Long Run

Rescheduling is not a cure-all for industry issues. It may improve balance sheets and attract capital, but won't bring major players like Wells Fargo without full legalization.

|

Don't Let Hidden Debt Fool You: How Cannabis Investors Can Tell If They Are Safe

Viridian Capital Advisors provides cannabis investors with a more comprehensive EV calculation compared to traditional methods.

|

Inside One Cannabis Company's Aggressive Loan-To-Own Strategy To Control Distressed Industry Players

SNDL's aggressive loan-to-own strategy is transforming the cannabis industry, as seen in its recent acquisition of Delta 9's debt to gain control over assets.

|

Canadian Cannabis Companies Are More Valuable Than Rivals In The U.S. - Here's Why

Understanding the valuation gap between U.S. Cannabis MSOs and Canadian LPs is crucial for investors... learn about the gap...

|

Does Size Matter? These Two Small-Cap Cannabis Stocks Are Masters Of Cash Flow And Credit Management

C21 Investments (OTC: CXXI) and Vext Science (OTC: VEXT) have demonstrated notable financial performance, particularly in cash flow and credit stability.

|

Executive Changes In Cannabis Industry You Should Know About, New Appointments & More

Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as CFO joined Viridian Capital Advisors's advisory board. David Vautrinas was appointed to serve as chief retail officer of RIV Capital.

|

Maryland, Ohio And Illinois Defy The Trend In M&A Activity: What Investors Can Learn

Despite an overall decline in mergers and acquisitions (M&A) across the cannabis industry, a few states are bucking the trend, showcasing growth and resilience.

|

How These 2 Nasdaq-Listed Marijuana Companies Found A Way To Raise $250M Without Tanking Their Stock

This week's Viridian Valuation Tracker investigates the valuation metrics of Canadian cultivation and retail companies with market caps over $100M.

|

Finally, Tax Refunds! These Cannabis Companies Will Get The Most Money Back If Rescheduling Happens

Significant tax benefits are anticipated for the cannabis industry, following President Joe Biden's confirmation of the administration's intent to reschedule cannabis from Schedule I to Schedule III.

|

Analysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37M

Cannabis equity analysts may need to revise their 2024 earnings estimates after first-quarter results from major multi-state operators (MSOs). According to a recent report by Viridian Capital Advisors, 10 MSOs surpassed EBITDA estimates by $37 million in the first quarter of 2024, indicating that initial projections may have been too conservative.

|

$581M In Deals: Top States Draw Major Cannabis Investments Despite Market Downturn

In the latest report from Viridian Capital Advisors, investment trends in the U.S. cannabis industry show a marked decrease, despite significant capital inflows in leading states such as California, New York and Massachusetts.

|

Big Players In U.S. Cannabis Could Play The Stock-Value Card In M&A, New Report Shows

As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to

|

Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies' Risk-Return Profiles

The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators (MSOs).

|

How Big Caps Rewrite Valuation Rules In Cannabis: Cash Puzzle For Companies Above And Below $500M

How do we look at cannabis companies' cash flow? What is their total value and what methods are used to assess their worth?

|

Cannabis Companies' Gains - U.S. Versus Canada: Averages Can Be Deceiving, Irrational Market Behavior To Blame?

Recent insights from Viridian Capital Advisors shed light on the bewildering trends in cannabis stocks. Year-to-date (YTD) data indicates that U.S. multi-state operators (MSOs) and Canadian licensed producers (LPs) have experienced drastically different fates. At a glance, U.S. MSOs show an average return of 26.4%, towering over Canadian LPs' modest 1.3%.

|

Beyond Amazon And Coca-Cola: Why Cannabis Is Catching Up To Blue Chip Stocks In Profitability

A recent report by Viridian Capital Advisors explores the valuation and growth prospects of cannabis stocks against those of well-established sectors like alco

|

What's The Net Worth Of These 4/20 Underdogs? Mid-Tier Cannabis Retailers & Cultivators Under The Spotlight

In the spotlight of Viridian Capital Advisors' latest Weekly Valuation Report are 16 Tier 2 and 3 U.S. cultivation and retail cannabis companies, each boasting market capitalizations between $10 million and $200 million.

|

Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%

Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis industry.

|

Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity

A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector.

|

Webinar: A Look At The Cannabis Industry's $700M Potential Tax Break Amid A 70% Drop In Capital Raises

MGO and Viridian Capital Advisors have joined forces to launch the Cannabis Capital Markets report.

|

35 Cannabis Innovators To Watch In 2024: Leaders Shaping The Green Revolution

Discover the stories and future prospects of 35 influential figures in the cannabis industry, driving innovation and shaping the evolving landscape.

|

Cannabis Stocks With Hidden Potential: A Closer Look At Attractively-Valued Tier-2 Firms

In a comprehensive report by Viridian Capital Advisors, the spotlight is on the valuations of companies within the U.S. cultivation and retail sector, specifically those boasting market caps ranging from $100 million to $500 million —commonly referred to as ‘Tier 2’ enterprises.

|

Trulieve Vs The IRS Over Millions Of Dollars In Tax Refund, Relocates One Of Its Florida Stores

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) announced on Friday the filing of amended federal tax returns with refund claims for several of the company's business entities for 2019, 2020 and 2021.

|